Stevanato Group S.p.A. (STVN) Insider Lin Buys 4,975 Shares

Insider Sue-Jean Lin purchased 4,975 shares of Stevanato Group S.p.A. on June 12, 2026.

By EarningsIQ Research Desk · Published Jun 26, 2026, 7:01 AM EDT · Updated Jun 27, 2026, 4:01 AM EDT

Reviewed by automated data checks against the source filing. How we make and check alerts

Sue-Jean Lin bought 4,975 shares of Stevanato Group S.p.A. ($STVN) on June 12, 2026. The trade was reported to the SEC in a Form 4 filing.

Since the trade, $STVN is down 0.8% after 1 week, up 15.8% after 1 month and up 10.7% to date (from the $17.08 close on Jun 12, 2026).

Find the original: STVN Form 4 filings on SEC EDGAR

STVN Stevanato Group S.p.A.

$18.90 -7.85% year to date

Daily close · Oct 16, 2026

Key Points

Sue-Jean Lin purchased 4,975 shares of Stevanato Group S.p.A. on June 12, 2026.
The stock traded around $18.39 on the day of the transaction, sitting between its 52-week low and high.
Multiple executives, including Mauro Stocchi and Dal Lago Marco, also transacted in company shares during June 2026.

Get $STVN trade alerts by text

We text you when insiders, Congress or big funds trade $STVN. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Stevanato Group S.p.A. alert may contain errors. Disclosures

Sue-Jean Lin Expands Stake in Stevanato Group S.p.A.

Insider Sue-Jean Lin acquired 4,975 shares of Stevanato Group S.p.A. NYSE: STVN on June 12, 2026. This purchase fits into a wider pattern of executive activity at the medical equipment maker during the month of June. The transaction took place as part of a series of reported buys and sales among top leaders at the firm.

Insider Buying and Selling at Stevanato Group S.p.A.

The recent purchase by Sue-Jean Lin joined a crowded calendar of insider movements at the healthcare company. Earlier in the month on June 9, Chief Business Strategy Officer Mauro Stocchi transacted 6,586 shares. On June 12, the same day as Lin's acquisition, several other leaders made moves. Karen Flynn and Elisabetta Magistretti each bought 4,975 shares, matching Lin's acquisition size. Meanwhile, Chief Financial Officer Dal Lago Marco parted with 7,997 shares on June 12. Madhavan Balachandran also added 4,975 shares to his holdings on that date.

Stock Valuation and Analyst Sentiment

Shares of Stevanato Group S.p.A. traded at $18.39 on the day of Sue-Jean Lin's transaction. The company has a forward P/E of 23.18 and a trailing P/E of 33.77. In September, financial firms adjusted their outlooks on the equity. On September 9, 2026, UBS kept a neutral rating while moving its price target to $23.00 from $28.00. The wider analyst group currently maintains a consensus buy recommendation with a mean target price of $24.47 based on 13 opinions.

What Stevanato Group S.p.A. Does

Stevanato Group S.p.A. designs and manufactures containment systems, diagnostic components, and drug delivery equipment for the global healthcare and pharmaceutical sectors. Its offerings include vials, syringes, auto-injectors, and engineering machinery used in drug manufacturing facilities. The company operates from its base in Italy and serves clients worldwide.

Looking Ahead at Upcoming Disclosures

Market participants will monitor future regulatory filings for any further changes in executive ownership. The company's next financial results are slated for release on November 5, 2026, providing an update on operational performance and revenues.

More on this

Source: Sue-Jean Lin's Form 4 filing on $STVN (Jun 12, 2026). Find the original filing: STVN Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts